• linkedin
  • Increase Font
  • Sharebar

    OCTA system offers exquisite views

    New technology provides elegant look at retinal microvasculature without fluorescein dye

    The latest advancement in optical coherence tomography (OCT) technology, a high-density OCT angiography (OCTA) system (AngioVueHD, OptoVue) provides benefits for both surgeons and patients.

    Perhaps the greatest advantage is that the technology facilitates improved evaluation of the retinal microvasculature without the patient having to undergo injection of fluorescein dye. The time required for patient evaluations is also decreased substantially.

    The new system is a boon for ophthalmologists, said Daniel D. Esmaili, MD.

    “The technology has done several things for us, the first of which is that we can now evaluate the retinal microvasculature without having to administer a dye as is required when performing fluorescein angiography,” said Dr. Esmaili, private practice at Retina-Vitreous Associates Medical Group, Los Angeles. “In addition, the system allows us to evaluate patients much more 

    conveniently and rapidly.”

    For example, in a patient with wet age-related macular degeneration (AMD), the clinician can easily evaluate the choroidal neovascular lesions periodically in a matter of seconds and as often as desired.

    OCTA images are obtained concurrently with the standard structural OCT images, which eliminates extra time that would be added to a different method of evaluation.

    Closer follow-up


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow

    var script= ' ';